Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0.477. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →James M. Cox Foundation
Grant: Trailsend Foundation
Prostate Cancer Foundation
Grant: Challenge Award
HHS | NIH | National Cancer Institute
Grant: P50-CA186786
HHS | NIH | National Cancer Institute
Grant: R35-CA231996
Prostate Cancer Foundation
Grant: Young Investigator Award
U.S. Department of Defense
Grant: W81XWH-21-1-0500
HHS | National Institutes of Health
Grant: 5T32-GM145470
NIGMS NIH HHS
Grant: T32 GM007863
NCI NIH HHS
Grant: R35 CA231996
NIGMS NIH HHS
Grant: T32 GM145470
NCI NIH HHS
Grant: P50 CA186786
National Institutes of Health
Grant: 1R35CA231996-01
Exploring Precision Oncology: From Gene Fusions to lncRNAs
National Institutes of Health
Grant: 5T32GM145470-03
Cellular and Molecular Biology at Michigan
National Institutes of Health
Grant: 5P50CA186786-09
Michigan Prostate SPORE
Fields of Study
MeSH Terms
Keywords